4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000055
Director acquired 2,120 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-20 | Exercise or conversion : show line 1 in the form | +2,120 | 151,340 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-18 | Grant or award : show line 2 in the form Restricted stock units | +2,816 | 2,816 | D |
| 2025-06-18 | Grant or award : show line 3 in the form Stock options (right to buy) | +15,768 | 15,768 | D |
| 2025-06-20 | Exercise or conversion : show line 4 in the form Restricted stock units | −2,120 | 0 | D |
Loading xslF345X05/wk-form4_1750710197.xml…